Drug interactions for the following drug(s)
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Applies to: Mirtazapine 15 MG Oral Tablet [Remeron] <> gabapentin 300 MG Oral Capsule
Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Applies to: Mirtazapine 15 MG Oral Tablet [Remeron] <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Mirtazapine and Gabapentin. Drug1 is resolved to mirtazapine, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Mirtazapine and Gabapentin enacarbil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.